4
Changes in Ownership
BlossomHill Therapeutics, Inc. Filed Acc 0000947871-26-000784
Director bought 625,000 shares at $16.00 ($10,000,000)
- Director acquired 2,089,279 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2026-08-10 | Conversion | +1,039,996 | 1,039,996 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-08-10 | Conversion | +1,049,283 | 2,089,279 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-08-10 | Purchase | +625,000 | $16.00 | $10,000,000 | 2,714,279 | I |
| Derivatives | |||||||
| ORBIMED ADVISORS LLC Director | 2026-08-10 | Conversion · Series A Preferred Stock | −1,039,996 | 0 | I | ||
| ORBIMED ADVISORS LLC Director | 2026-08-10 | Conversion · Series B Preferred Stock | −1,049,283 | 0 | I | ||
| Open-market purchases · 625,000 sh · avg $16.00 · $10,000,000 | |||||||
Loading xslF345X06/ownership.xml…